Editor's Pick

Aug 9, 2022

Castle Bio Q2 Growth Driven by Skin Cancer Testing as New Acquisitions Boost Sales
Premium

Aug 8, 2022

CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection
Premium

Aug 3, 2022

Exact Sciences Reaps Q2 Rewards From Growth in Colon Cancer Screening
Premium

Jul 25, 2022

Highly Anticipated Cepheid Omni Point-of-Care System Falls Off Radar
Premium

Jul 22, 2022

Lung Cancer MRD Study Bolsters Validity Evidence, Suggests Longitudinal Test Cutoff
Premium

Jun 22, 2022

Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium

Jun 13, 2022

At ESHG, Thermo Fisher Official Predicts IVDR Will Push Labs to Replace LDTs With Commercial Kits
Premium

Jun 8, 2022

New Data Suggests Liquid Biopsy Provides Early ID of Breast Cancer Patients Destined to Recur
Premium

Jun 7, 2022

Monkeypox Spurs Test Development, Though Scope of Outbreak Remains Unclear
Premium

May 20, 2022

MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing
Premium

May 20, 2022

Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests

May 18, 2022

California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom
Premium

May 18, 2022

Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium

May 9, 2022

Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism
Premium

Apr 28, 2022

Mirvie Developing Cell-Free RNA Blood Tests to Predict Pregnancy Complications
Premium

Apr 20, 2022

Natera Adds Clinical Utility Evidence for Cell-Free DNA in Allograft Health
Premium

Apr 7, 2022

MALDI Clinical Microbiology Releases Bring New Features, Could Open Additional US Markets
Premium

Apr 7, 2022

UK Study Supports Clinical Adoption of Genedrive Newborn Hearing Loss Test Within NHS
Premium

Mar 29, 2022

Tufts University, NIH Leveraging Phospholipid Biomarkers to Develop Early Lyme Disease Test
Premium

Mar 23, 2022

Diadem to Launch Alzheimer's Screening Assay This Year While Developing Confirmatory Test
Premium